Verapamil: A Review of its Pharmacological Properties and Therapeutic Use

[1]  M. Kohlhardt,et al.  New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres. Studies with the voltage clamp technique , 1972, Experientia.

[2]  J. Atterhög,et al.  Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men , 1975, European Journal of Clinical Pharmacology.

[3]  L. Rydén,et al.  The haemodynamic effect of verapamil , 1971, European Journal of Clinical Pharmacology.

[4]  K. Golenhofen,et al.  Selective suppression of some components of spontaneous activity in various types of smooth muscle by iproveratril (verapamil) , 2004, Pflügers Archiv.

[5]  B. Singh,et al.  A fourth class of anti-dysrhythmic action? Effect of verapamil and ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. , 1972, Cardiovascular research.

[6]  Bramahn . Singh,et al.  Effects of intravenous verapamil on hemodynamics in patients with heart disease. , 1977, American heart journal.

[7]  B. Singh,et al.  The Effect of Verapamil on Experimental Myocardial Ischaemia with a Particular Reference to Regional Myocardial Blood Flow and Metabolism * , 1977, Australian and New Zealand journal of medicine.

[8]  J. Lowe,et al.  Effect of the Calcium Antagonist Verapamil on Necrosis following Temporary Coronary Artery Occlusion in Dogs , 1977, Circulation.

[9]  A. Resmini.  The conduction of the cardiac impulse : P. F. Cranefeld, Futura Publ. Co., Mount Kisko, N.Y. (1975), 404 pp., $ 27.50. , 1977 .

[10]  W. Nayler,et al.  A protective effect of verapamil on hypoxic heart muscle. , 1976, Cardiovascular research.

[11]  J. Angus,et al.  Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction. , 1976, Cardiovascular research.

[12]  M. Eichelbaum,et al.  Physiological disposition of verapamil in man. , 1976, Cardiovascular research.

[13]  T. Okada.  Effect of verapamil on electrical activities of SA node, ventricular muscle and Purkinje fibers in isolated rabbit hearts. , 1976, Japanese circulation journal.

[14]  R. Sutton,et al.  Hemodynamic effects of verapamil and practolol in man. , 1976, European journal of cardiology.

[15]  M. Hartikainen,et al.  Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia. , 1976, European journal of cardiology.

[16]  R. G. Mcallister,et al.  Fluorometric assay of verapamil in biological fluids and tissues. , 1976, Journal of pharmaceutical sciences.

[17]  V. Balasubramanian,et al.  Verapamil in ischaemic heart disease—quantitative assessment by serial multistage treadmill exercise , 1976, Postgraduate medical journal.

[18]  E. Sivertssen,et al.  Registration of sinus node recovery time in patients with sinus rhythm and in patients with dysrhythmias. , 2009, Acta medica Scandinavica.

[19]  K. Landmark,et al.  Verapamil in the treatment of atrial tachycardia with block. , 2009, Acta medica Scandinavica.

[20]  Bn.  Verapamil and the heart: Pharmacological and Therapeutic Considerations. , 1975 .

[21]  Bramahn . Singh,et al.  Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. , 1975, American heart journal.

[22]  M. Schlepper,et al.  The pharmacodynamics of orally taken verapamil and verapamil retard as judged by their negative dromotropic effects. , 1975, Arzneimittel-Forschung.

[23]  B. Singh,et al.  Effects of verapamil on infarct size following experimental coronary occlusion. , 1975, Cardiovascular research.

[24]  M. Rosen,et al.  Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. , 1975, American heart journal.

[25]  G. Burrows,et al.  Intracardiac conduction defects following overdose of tricyclic antidepressant drugs. , 1975, European journal of cardiology.

[26]  G. Rona,et al.  The Metabolism of contraction , 1975 .

[27]  Norris Rm,et al.  Reduction in infarct size following experimental coronary occlusion by administration of verapamil. , 1975 .

[28]  B. Lewis,et al.  Immediate haemodynamic effects of verapamil in man. , 1975, Cardiology.

[29]  P. Dalsgaard,et al.  Assessment of verapamil in the treatment of angina pectoris. , 1975, European journal of cardiology.

[30]  J. Vohra,et al.  Verapamil induced premature ventricular beats before reversion of supraventricular tachycardia. , 1974, British heart journal.

[31]  A. L. Wit,et al.  Effect of Verapamil on the Sinoatrial and Atrioventricular Nodes of the Rabbit and the Mechanism by Which it Arrests Reentrant Atrioventricular Nodal Tachycardia , 1974, Circulation research.

[32]  D. Krikler.  Verapamil in cardiology. , 1974, European journal of cardiology.

[33]  N. Sperelakis,et al.  Verapamil blockade of slow Na+ and Ca++ responses in myocardial cells. , 1974, The Journal of pharmacology and experimental therapeutics.

[34]  W. Nayler,et al.  Verapamil and the myocardium , 1974, Postgraduate medical journal.

[35]  D. Krikler,et al.  Verapamil in the treatment of paroxysmal supraventricular tachycardia , 1974, Postgraduate medical journal.

[36]  J. Vohra,et al.  Cycle length alternation in supraventricular tachycardia after administration of verapamil. , 1974, British heart journal.

[37]  Johnson Ad,et al.  Coronary arterial spasm: a clinical entity? , 1974 .

[38]  E. Sowton,et al.  The effect of Verapamil on the cardiac conduction system in man , 1974 .

[39]  S. Greenberg,et al.  Iproveratril: a nonspecific antagonist of peripheral vascular reactivity. , 1974, Canadian journal of physiology and pharmacology.

[40]  E. Sowton,et al.  Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome. , 1974, British heart journal.

[41]  B. Wüsten,et al.  The effects of anti-anginal drugs on AV-conduction in normal subjects. , 1974, Arzneimittel-Forschung.

[42]  A. L. Wit,et al.  Effect of Verapamil on the Normal Action Potential and on a Calcium Dependent Slow Response of Canine Cardiac Purkinje Fibers , 1974 .

[43]  D P Zipes,et al.  Effects of Agents which Inhibit the Slow Channel on Sinus Node Automaticity and Atrioventricular Conduction in the Dog , 1974, Circulation research.

[44]  K. Rasmussen,et al.  Digitalis and atrial tachycardia with block. , 1974, British heart journal.

[45]  P. Dresel,et al.  Effect of digitalis on atrioventricular conduction , 1974 .

[46]  R. Carleton,et al.  Coronary arterial spasm: a clinical entity? , 1974, Modern concepts of cardiovascular disease.

[47]  M. Schlepper,et al.  Influence of various antiarrhythmic drugs (Aprindine, ajmaline, verapamil, oxprenolol, orciprenaline) on functional properties of accessory A-V pathways. , 1974, Acta cardiologica.

[48]  J. Kvasnicka,et al.  Action of verapamil on sinus node, atrioventricular, and intraventricular conduction. , 1973, British heart journal.

[49]  A. L. Wit,et al.  Electrophysiological Properties of Cardiac Muscle in the Anterior Mitral Valve Leaflet and the Adjacent Atrium in the Dog: POSSIBLE IMPLICATIONS FOR THE GENESIS OF ATRIAL DYSRHYTHMIAS , 1973, Circulation research.

[50]  P. Cranefield,et al.  The Electrical Activity of Canine Cardiac Purkinje Fibers in Sodium-Free, Calcium-Rich Solutions , 1973, The Journal of general physiology.

[51]  E. Sowton,et al.  Concealed bypasses of the atrio-ventricular node in patients with paroxysmal supraventricular tachycardia , 1973 .

[52]  B. Livesley,et al.  Double-blind Evaluation of Verapamil, Propranolol, and Isosorbide Dinitrate against a Placebo in the Treatment of Angina Pectoris , 1973, British medical journal.

[53]  K. Cullen.  Future relationships of hospitals in population medicine. , 1973, Australian and New Zealand journal of medicine.

[54]  B. Lewis,et al.  Verapamil in life-threatening tachyarrhythmias. , 1972, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[55]  M. Entman,et al.  Mechanisms of calcium accumulation and transport in cardiac relaxing system (sarcoplasmic reticulum membranes): effects of Verapamil, D-600, X537A and A23187. , 1972, Journal of molecular and cellular cardiology.

[56]  B. N. Goldreyer.  Intracardiac electrocardiography in the analysis and understanding of cardiac arrhythmias. , 1972, Annals of internal medicine.

[57]  H. Sacks,et al.  Verapamil in cardiac arrhythmias. , 1972, British medical journal.

[58]  M. Benaim.  Asystole after verapamil. , 1972, British medical journal.

[59]  D. Krikler,et al.  Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias , 1972, British medical journal.

[60]  W. Nayler,et al.  Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. , 1972, Cardiovascular research.

[61]  G. Haeusler.  Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. , 1972, The Journal of pharmacology and experimental therapeutics.

[62]  Shand Dg,et al.  The disposition of propranolol. I. Elimination during oral absorption in man. , 1972 .

[63]  B. Singh,et al.  A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. , 1972, Cardiovascular research.

[64]  D. Shand,et al.  The disposition of propranolol. I. Elimination during oral absorption in man. , 1972, Pharmacology.

[65]  H. Mcilhenny.  Metabolism of [14C]verapamil. , 1971, Journal of medicinal chemistry.

[66]  L. Schamroth.  Immediate effects of intravenous verapamil on atrial fibrillation. , 1971, Cardiovascular research.

[67]  B. Singh,et al.  Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular Muscle , 1971, Circulation research.

[68]  G. Brichard,et al.  Verapamil in cardiac dysrhythmias during anaesthesia. , 1970, British journal of anaesthesia.

[69]  W. Huber,et al.  Klinisch-experimentelle Untersuchungen über die blutdrucksenkende Wirkung von Verapamil , 1970 .

[70]  F. Bender.  [Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil]. , 1970, Arzneimittel-Forschung.

[71]  B. Singh,et al.  The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle , 1970, British journal of pharmacology.

[72]  Hills Ea.  Iproveratril and bronchial asthma. , 1970 .

[73]  H. L. Garvey.  The mechanism of action of verapamil on the sinus and AV nodes. , 1969, European journal of pharmacology.

[74]  M. Winbury,et al.  Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates. , 1969, The Journal of pharmacology and experimental therapeutics.

[75]  E. Sowton,et al.  The use of beta-adrenergic receptor blocking drugs in dysrhythmias. , 1969, Progress in cardiovascular diseases.

[76]  H. Tritthart,et al.  [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium]. , 1969, Pflugers Archiv : European journal of physiology.

[77]  A. Kaumann,et al.  Prevention of ventricular fibrillation induced by coronary ligation. , 1968, The Journal of pharmacology and experimental therapeutics.

[78]  G. Sandler,et al.  Clinical Evaluation of Verapamil in Angina Pectoris , 1968, British medical journal.

[79]  H. Zimmerman,et al.  Coronary arterial spasm. , 1968, Diseases of the chest.

[80]  W. Nayler,et al.  Some effects of iproveratril (Isoptin) on the cardiovascular system. , 1968, The Journal of pharmacology and experimental therapeutics.

[81]  E. Rodrigues-Pereira,et al.  The actions of verapamil on experimental arrhythmias. , 1968, Arzneimittel-Forschung.

[82]  G. Schmitt.  [On the protective effect of iproveratil in myocardial diseases due to hypertension in animal experiment]. , 1967, Die Medizinische Welt.

[83]  G. Ross,et al.  Cardiovascular actions of iproveratril. , 1967, The Journal of pharmacology and experimental therapeutics.

[84]  E. Letley,et al.  WHAT IS A β-BLOCKER? , 1967 .

[85]  E. Letley,et al.  What is a beta-blocker? , 1967, Lancet.

[86]  J. R. Schmid,et al.  A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol. , 1967, The Journal of pharmacology and experimental therapeutics.

[87]  W. Nayler,et al.  Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields. , 1967, American heart journal.

[88]  J. Mignault.  Coronary cineangiographic study of intravenously administered isoptin. , 1966, Canadian Medical Association journal.

[89]  A. Luisada,et al.  DOUBLE BLIND EVALUATION OF ORALLY ADMINISTERED IPROVERATRIL IN PATIENTS WITH ANGINA PECTORIS , 1966, The American journal of the medical sciences.

[90]  R. Bing,et al.  Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium. , 1966, The American journal of cardiology.

[91]  K. I. Melville,et al.  CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRIL. , 1965, Canadian journal of physiology and pharmacology.

[92]  P. Hoffmann.  [TREATMENT OF CORONARY CIRCULATORY DISORDERS WITH ISOPTIN IN GENERAL PRACTICE]. , 1964, Medizinische Klinik.

[93]  K. I. Melville,et al.  IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION. , 1964, Canadian Medical Association journal.

[94]  H. Klepzig,et al.  Klinische Untersuchung über die Wirkung von Isoptin und Isoptin S bei Patienten mit Koronarinsuffizienz , 1963 .

[95]  W. Appel.  [(N-methyl-N-homoveratryl)-gamma-aminopropyl] -3,4-dimethoxyphenylacetonitrile, its detection in biological materials and its behavior in blood]. , 1962, Arzneimittel-Forschung.

[96]  H. Haas,et al.  [(N-methyl-N-homoveratryl)-gamma-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile, a substance with coronary vasodilating properties]. , 1962, Arzneimittel-Forschung.